De Novo device
NEPHROCHECK Test System
Astute Medical, Inc. · Acute Kidney Injury Test System (PIG, Class II) · First FDA decision Sep 5, 2014, newest Nov 16, 2017Kidney failure and dialysis
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
3
De Novo pathway
Device trials
4
Naming "NEPHROCHECK"
MAUDE reports
1
Brand "NEPHROCHECK", since 2015
PubMed studies
79
Mentioning "NEPHROCHECK"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing NEPHROCHECK Test System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 3 of 3 decisions filed under this name.
- NEPHROCHECK Test System510(k)
K171482 · Decided Nov 16, 2017 · 181 days after receipt
Device type: Acute Kidney Injury Test System (PIG) · Laboratory Medicine & Pathology
K153165 · Decided Jun 1, 2016 · 212 days after receipt
Device type: Acute Kidney Injury Test System (PIG) · Laboratory Medicine & Pathology
- NEPHROCHECK TEST SYSTEMNew device typeDe Novo
DEN130031 · Decided Sep 5, 2014 · 457 days after receipt
Device type: Acute Kidney Injury Test System (PIG) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "NEPHROCHECK", any status and sponsor, newest update first.
- Can Nephrocheck™ Predict the Reversibility of Early, Acute Kidney Injury During Septic Shock?Completed
Centre Hospitalier Universitaire, AmiensAcademic, hospital or other
NCT02812784 · 184 participants · Start Sep 16, 2015 · Primary completion Feb 11, 2019
Device: Nephrocheck TM · For: Heading
Sites: Amiens, France; Avranches, France; Cahors, France · 11 sites in all
BioMérieuxNot on our public-company list
NCT04434209 · 19 participants · Start Jan 19, 2021 · Primary completion Feb 14, 2022
Device: Subject management guided by NephroCheck® test · For: Sepsis; Acute Kidney Injury; Septic Shock
Sites: Shreveport, Louisiana; Boston, Massachusetts; New York, New York · 12 sites in all
Shanghai Children's Medical CenterAcademic, hospital or other
NCT03963284 · 350 participants (planned) · Start Jun 2019 · Primary completion Dec 2019
Device: NephroCheck test · For: Acute Kidney Injury; Cardiac Disease; Surgery
1 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "NEPHROCHECK", and for the whole product code for context.
This brand
1 reports: 1 malfunction, 0 injury, 0 death
Whole product code PIG
1 reports: 1 malfunction, 0 injury, 0 death
Newest reports for this brand
- VIDAS NEPHROCHECK®Malfunction
8020790-2024-00003 · Received Apr 12, 2024 · Event dated Mar 28, 2024
Device type: Acute Kidney Injury Test System (PIG)
Device problem as coded: Low Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "NEPHROCHECK"[tiab]. The summary above synthesizes these.
- NephroCheck® Quality Test.
Naorungroj T, Serpa Neto A, Yanase F, et al. · Blood Purif · 2021Letter
- Nephrocheck®: Checkmate or reality check?
El-Khoury JM · Ann Clin Biochem · 2021Editorial, Comment
- NephroCheck at 10: addressing unmet needs in AKI diagnosis and risk stratification.
Martin-Cleary C, Sanz AB, Avello A, et al. · Clin Kidney J · 2023Editorial
- NephroCheck as a Predictor of Acute Kidney Injury Following Coronary Artery Bypass Graft Surgery.
Khalpey Z, Jutla P, Khalpey ZI, et al. · Cureus · 2024
- The NephroCheck bedside system for detecting stage 3 acute kidney injury after open thoracoabdominal aortic repair.
Doukas P, Frese JP, Eierhoff T, et al. · Sci Rep · 2023Observational Study, Multicenter Study
- Serum Creatinine Levels and Nephrocheck® Values With and Without Correction for Urine Dilution-A Multicenter Observational Study.
Hahn RG, Yanase F, Zdolsek JH, et al. · Front Med (Lausanne) · 2022
- Biomarkers of Drug-Induced Kidney Toxicity.
Griffin BR, Faubel S, Edelstein CL · Ther Drug Monit · 2019Research Support, U.S. Gov't, Non-P.H.S., Review
- NephroCheck: should we consider urine osmolality?
Noto A, Cortegiani A, David A · Crit Care · 2019Letter
- Urinary Cell-Cycle Arrest Biomarkers as Early Predictors of Acute Kidney Injury After Ventricular Assist Device Implantation or Cardiac Transplantation.
Alam A, Jamil AK, Van Zyl JS, et al. · J Cardiothorac Vasc Anesth · 2022Research Support, Non-U.S. Gov't
- Urinary Cell Cycle Arrest Biomarkers and Diuretic Efficiency in Acute Heart Failure.
Núñez-Marín G, Romero-González G, Bover J, et al. · Cardiorenal Med · 2024Research Support, Non-U.S. Gov't
- Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department (BRAVA): A Multicenter Study Evaluating Urinary TIMP-2/IGFBP7.
Yang HS, Hur M, Lee KR, et al. · Ann Lab Med · 2022Multicenter Study, Observational Study
- Nephrocheck® results should be corrected for dilution.
Hahn RG, Zdolsek J · Acta Anaesthesiol Scand · 2017Letter
Other devices of this type
Also filed under product code PIG.
- ProNephro AKI (NGAL)Bioporto Diagnostic, Inc. · 510(k) 2023
- Vidas NephrocheckBiomérieux SA · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.